Economic Conditions: General economic growth or recession can influence investor sentiment and impact consumer spending on healthcare services, affecting Seer's potential revenue and stock price.

Company Performance: Seer's financial results, including revenue growth, profitability, and market share, directly affect investor confidence and stock valuation.

Regulatory Environment: Changes in healthcare regulations, drug pricing policies, and approvals for new treatments can create uncertainty and impact Seer's future earnings.

Competition: The presence of competing diagnostic technologies and companies affects Seer's market position and ability to attract customers, influencing its stock price.

Technological Advancements: Breakthroughs in proteomic research or the development of competing technologies can impact the perceived value of Seer's platform.

Investor Sentiment: Overall market sentiment and risk appetite can impact the demand for Seer's stock, regardless of its fundamental performance.

Interest Rates: Higher interest rates can make borrowing more expensive for companies and reduce the attractiveness of stocks compared to bonds, potentially affecting Seer's valuation.